BALA CYNWYD, Pa. (AP) — BALA CYNWYD, Pa. (AP) — Larimar Therapeutics, Inc. (LRMR) on Monday reported a loss of $28.8 million in its fourth quarter.
The Bala Cynwyd, Pennsylvania-based company said it had a loss of 45 cents per share.
The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
For the year, the company reported a loss of $80.6 million, or $1.32 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LRMR at https://www.zacks.com/ap/LRMR
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
